Anxiety among the parents of pediatric patients receiving IVIG therapy during the Covid-19 pandemic

dc.authoridhttps://orcid.org/0000-0001-5245-2488en_US
dc.authoridhttps://orcid.org/0000-0002-0731-5799en_US
dc.authoridhttps://orcid.org/0000-0001-8451-0099en_US
dc.authoridhttps://orcid.org/0000-0001-5556-3175en_US
dc.authoridhttps://orcid.org/0000-0002-7868-5338en_US
dc.contributor.authorYılmaz Topal, Özge
dc.contributor.authorMetin, Ayşe
dc.contributor.authorÇöp, Esra
dc.contributor.authorŞenses Dinç, Gülser
dc.contributor.authorÜneri, Özden Şükran
dc.date.accessioned2023-08-06T09:33:52Z
dc.date.available2023-08-06T09:33:52Z
dc.date.issued2021en_US
dc.departmentİktisadi İdari ve Sosyal Bilimler Fakültesien_US
dc.description.abstractBackground. Symptomatic COVID-19 cases in children occur mostly in those with primary immunodeficiency (PID), chronic lung diseases, and heart disease. Guidelines recommend that patients with PID continue to use their regular medication during the pandemic. Objectives. This study aimed to evaluate anxiety related to COVID-19 in the parents of patients receiving intravenous immunoglobulin (IVIG) treatment in our hospital and to evaluate the effect of their anxiety on the continuity of treatment. Methods. The parents of the patients who underwent IVIG therapy in our clinic during the pandemic (between May 15, 2020 and July 1, 2020) were included in our study. Results. Twenty-seven patients with PID whose IVIG therapy was initiated before the pandemic and 29 nonPID control subjects were included in the study. All patients received IVIG treatment in our clinic continued treatment during the pandemic at the same dose intervals. Parents in the IVIG group had significantly higher state (p=0.003) and trait (p=0.003) anxiety scores compared to control parents. IVIG group showed statistically significant higher scores in Beck depression inventory, than the control group (p=0.002). Conclusions. The parents of PID patients who needed to come to the hospital for IVIG therapy had higher anxiety levels than the parents of similar aged children who presented to our clinic for different complaints between the same dates. Despite their concerns, the parents of all patients under IVIG therapy maintained treatment continuity at the recommended treatment intervals. None of our immunodeficient patients who presented for treatment during the pandemic contracted COVID-19 infection during our study.en_US
dc.identifier.doi10.24953/turkjped.2021.05.008en_US
dc.identifier.endpage810en_US
dc.identifier.issn0041-4301
dc.identifier.issue5en_US
dc.identifier.pmid34738362en_US
dc.identifier.scopus2-s2.0-85119921609en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage801en_US
dc.identifier.trdizinid514200en_US
dc.identifier.urihttps://hdl.handle.net/11363/5183
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/514200
dc.identifier.urihttps://doi.org/
dc.identifier.volume63en_US
dc.identifier.wosWOS:000717462100008en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorÜneri, Özden Şükran
dc.language.isoenen_US
dc.publisherTURKISH J PEDIATRICS, P K 66 SAMANPAZARI, 06240 ANKARA, TURKEYen_US
dc.relation.ispartofThe Turkish Journal of Pediatricsen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectintravenous immunoglobulin treatmenten_US
dc.subjectanxietyen_US
dc.subjectCOVID-19en_US
dc.subjectpandemicen_US
dc.titleAnxiety among the parents of pediatric patients receiving IVIG therapy during the Covid-19 pandemicen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
pdf_TJP_2353.pdf
Boyut:
374.67 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale / Article
Lisans paketi
Listeleniyor 1 - 1 / 1
[ N/A ]
İsim:
license.txt
Boyut:
1.56 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: